Management of Anticoagulants in the Periprocedural Period for Patients With Cancer
Publication Date
2014
Journal Title
J Natl Compr Canc Netw
Abstract
Patients with cancer undergo surgeries and procedures for various purposes, including prophylaxis, diagnosis, staging, cure, debulking, palliation, and reconstruction. The diagnosis of cancer itself, along with the well-established complication of venous thromboembolism (VTE), places these patients at risk for perioperative thromboembolism. It is also well-established that continuing patients on oral anticoagulation therapy during the periprocedural period is associated with an increased risk of bleeding. Rates of periprocedural VTE and major bleeding are significantly higher in patients with cancer, presenting a complex problem for clinicians in terms of periprocedural anticoagulation management. This article reviews the current recommendations regarding periprocedural anticoagulation management in patients with cancer.
Volume Number
12
Issue Number
12
Pages
1713-1720
Document Type
Article
EPub Date
2014/12/17
Status
Faculty, Northwell Researcher
Facility
School of Medicine; Northwell Health
Primary Department
General Internal Medicine
PMID
This document is currently not available here.
COinS
Comments
Hofstra Northwell School of Medicine and Northwell Health currently do not subscribe to this title. If you are an affiliate and would like to access the full text please request it via interlibrary loan via Hofstra Northwell School of Medicine ILL (faculty and students only) or Northwell Health ILL